DELRAY BEACH, Fla., Oct. 20, 2022 (GLOBE NEWSWIRE) — PetMed Express, Inc. (PETS) (the “Company”), Your Trusted Pet Health ExpertTM, will hold a conference call on Monday, November 7, 2022 at 4:30pm Eastern Time to discuss its financial results for the second quarter ended September 30, 2022. Financial results will be issued in a press release prior to the call.
PetMed Express management will host the conference call, followed by a question and answer session.
Date: Monday, November 7, 2022
Time: 4:30 Eastern Time (1:30 Pacific Time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
The Company will also provide a link at https://www.1800petmeds.com/investor.html for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.
A telephonic replay of the conference call will also be available through November 21, 2022.
Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13733883
About PetMed Express
Founded in 1996, PetMeds is Your Trusted Pet Health ExpertTM, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at www.petmeds.com.
Investor Contact:
MZ North America
Brian M. Prenoveau, CFA
investor@petmeds.com
(561) 374-0177
Media Relations:
Mary Eva Tredway
Maryeva@butinpr.com
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving…